C
C. Smith
Researcher at The Forsyth Institute
Publications - 21
Citations - 6990
C. Smith is an academic researcher from The Forsyth Institute. The author has contributed to research in topics: Clinical attachment loss & Treponema denticola. The author has an hindex of 19, co-authored 21 publications receiving 6446 citations.
Papers
More filters
Journal ArticleDOI
Microbial complexes in subgingival plaque
TL;DR: The purpose of the present investigation was to attempt to define communities using data from large numbers of plaque samples and different clustering and ordination techniques, which related strikingly to clinical measures of periodontal disease particularly pocket depth and bleeding on probing.
Journal ArticleDOI
The effect of SRP on the clinical and microbiological parameters of periodontal diseases
TL;DR: Clinical improvement post-SRP was accompanied by a modest change in theSubgingival microbiota, primarily a reduction in P. gingivalis, B. forsythus and T. denticola, suggesting potential targets for therapy and indicating that radical alterations in the subgingival bacteria may not be necessary or desirable in many patients.
Journal ArticleDOI
Subgingival microbiota in healthy, well‐maintained elder and periodontitis subjects
A. D. Haffajee,M. A. Cugini,Anne C.R. Tanner,R. P. Pollack,C. Smith,Ralph Kent,Sigmund S. Socransky +6 more
TL;DR: The data suggest an etiologic role for B. forsythus, P. gingivalis, T. denticola and S. noxia in adult periodontitis.
Journal ArticleDOI
Use of checkerboard DNA–DNA hybridization to study complex microbial ecosystems
Sigmund S. Socransky,A. D. Haffajee,C. Smith,Lynn Martin,J. A. Haffajee,N. G. Uzel,J. M. Goodson +6 more
TL;DR: DNA probes used in the checkerboard DNA-DNA format provide a useful tool for the enumeration of bacterial species in microbiologically complex systems.
Journal ArticleDOI
The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases: 12-month results.
TL;DR: The data suggest that the maintenance phase of therapy may be essential in consolidating clinical and microbiological improvements achieved as a result of initial therapy.